Efficacy and Safety of TRA16 Administered Orally in Patients With Enteric Hyperoxaluria (EH).

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
A Phase II, Multi-center, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of TRA16 Administered Orally in Patients with Enteric Hyperoxaluria (EH).
Epistemonikos ID: 9144e90b1ab002ce7aacde25d6ebba6b1d892513
First added on: Oct 14, 2026